Schweizeraktien.net shares SIX Sparks IPO Academy Kick off event
In press
American Physiological Society selects the publication by Öhnstedt et al 2024 describing the MOA and preclinical PoC for ILP100-Oral as a APSselect publication
American Journal of Physiology-Gastrointestinal and Liver Physiology, June 2024 issue Title: Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models Authors: Emelie Öhnstedt, Cristian Doñas, Kristel Parv, Yanhong Pang, Hava Lofton Tomenius, Macarena Carrasco López, Venkata Ram Gannavarapu, Jacueline Choi, Maria Ovezik, Peter Frank, Margareth Jorvid, Stefan Roos, Evelina Vågesjö, and Mia Phillipson
ILP100-Topical data highlighted in Article from American Society for Microbiology
Special thanks to the author PhD student Vilhelmiina Haavisto, ETH Zurich, for the very well written piece and the interesting folklore history of Angels Glowing, nature is fantastic, especially when bioluminescent and when engineering is possible to utilise the already existing properties in new ways for the benefit of people.
Ilya Pharma CEO and CFO giving update in BeyondBiotech Podcast #11 in August
Beyondbiotech August episode 11, Rounding up news of the week and interviewing interesting companies - Yes also Ilya Pharma - please hear our CEO Evelina Vågesjö and CFO Oskar Lund give an update and share some details around the latests patents approved - at 29:50 to 43:00.